A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Erlotinib 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue
Abstract: A formulation for preparing Erlotinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, erlotinib, hazardous medication, cancer, antineoplastic agent, EGFR inhibitor
Related Categories: CANCER AND AIDS, FORMULATIONS, HAZARDOUS DRUGS
Download in electronic PDF format for $45
| Related Articles from IJPC | ||||
| Title (Click for Abstract / Details) | Author | Issue | Page | View/Buy |
|---|---|---|---|---|
| Veterinary Transdermal Medications: A to Z | Davidson Gigi S | Mar/Apr 2003 | 106-113 | Buy |
| Wetting and/or Solubilizing Agents, Featured Excipient: | Allen Loyd V Jr | Jul/Aug 2001 | 310-312 | Buy |
| Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh | Allen Loyd V Jr | Nov/Dec 2003 | 449-450 | Buy |
| Erlotinib 10-mg/mL Oral Suspension | Allen Loyd V Jr | Nov/Dec 2016 | 508 | Buy |
| Imatinib 40-mg/mL Oral Suspension | Allen Loyd V Jr | Nov/Dec 2016 | 510 | Buy |
| Lapatinib Ditosylate 50-mg/mL Oral Suspension | Allen Loyd V Jr | Nov/Dec 2016 | 511 | Buy |
| Basics of Compounding for Cough | Allen Loyd V Jr | Nov/Dec 2004 | 462-465 | Buy |
| Compounding for Cancer in Companion Animals | Mixon William, Northrup Nicole, Vail Jane | Jan/Feb 2009 | 42-49 | Buy |
| Compounding for the Effects of Weapons of Mass Destruction | Sammarco Domenic A | Jan/Feb 2003 | 10-15 | View Sample |
| Antineoplastic Agents | Ashworth Lisa D | Jul/Aug 2001 | 268-271 | Buy |